Author:
Shing Jaimie Z,Hu Shangying,Herrero Rolando,Hildesheim Allan,Porras Carolina,Sampson Joshua N,Schussler John,Schiller John T,Lowy Douglas R,Sierra Mónica S,Carvajal Loretto,Kreimer Aimée R,Cortés Bernal,González Paula,Herrero Rolando,Jiménez Silvia E.,Porras Carolina,Rodríguez Ana Cecilia,Hildesheim Allan,Kreimer Aimée R.,Lowy Douglas R.,Schiffman Mark,Schiller John T.,Sherman Mark,Wacholder Sholom,Pinto Ligia A.,Kemp Troy J.,Sidawy Mary K.,Quint Wim,van Doorn Leen-Jan,Struijk Linda,Palefsky Joel M.,Darragh Teresa M.,Stoler Mark H.
Reference24 articles.
1. Biological agents,2012
2. Burden of human papillomavirus (HPV)-related cancers attributable to HPx1/16/18/31/33/45/52 and 58;de Sanjosé;JNCI Cancer Spectr,2019
3. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors;Arbyn;Cochrane Database Syst Rev,2018
4. Durability of cross-protection by different schedules of the bivalent HPV vaccine: the CVT trial;Tsang;J Natl Cancer Inst,2020
5. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial;Wheeler;Lancet Oncol,2012
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献